Raymond Y. Huang, MD, Ph.D., of the Department of Radiology at Brigham and Women’s Hospital, is the corresponding author of a paper published in the Journal of Clinical Oncology, “Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204.”
Of Interest
3D models of uveal melanoma offer hope for improved treatments
Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in adults. Their goal is to use these models to better understand how this disease works and develop treatments for unmet patient needs.
Melanoma study identifies a mechanism for eliminating harmful cells from cancer treatment
After treating a tumor with chemotherapy and radiotherapy, cells known as senescent cells can appear. These are cells that do not divide, are involved in the aging process, and are resistant to cell death, but are still metabolically active in the human body. When they accumulate, they can jeopardize the patients’ recovery. Now, a UB-led study describes for the first time a molecular mechanism that could drive the design of strategies to eliminate senescent cells in cancer patients.
Air Pollution Exposure May Be Protective for Melanoma Risk
WEDNESDAY, Jan. 22, 2025 (HealthDay News) — Exposure to particulate matter (PM) with diameters of 10 µm (PM10) or with diameters that are 2.5 µm or smaller (PM2.5) seems to have a protective effect on melanoma risk, potentially due to the reduction in ultraviolet radiation exposure, according to a study published online Jan. 17 in the Journal of the European Academy of Dermatology and Venereology.